Where does Daxor Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Daxor Corp. ranks #39,758 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Daxor Corp. hold?

Daxor Corp. holds 6 US utility patents granted between 2015 and 2025, spanning 5 technology areas.

What is Daxor Corp.'s Innovation Score?

Daxor Corp. has an Innovation Score of 36.3 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Daxor Corp. focus on?

Daxor Corp.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5 patents, ranking #3,118 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Daxor Corp.'s patent grant rate increasing or decreasing?

Daxor Corp.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Daxor Corp.'s patents?

Daxor Corp.'s patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Daxor Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Daxor Corp.

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Daxor ranks #39,758 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#39,758
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.3/100): 13.8
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R39758 · US Corporation #39,758 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #39,758/49,997
PHOTO-FINISH Danimer IPCo
CPC-NARROW A61B · 5 areas
INNOV-THIN 36.3/100
CLAIMS-RICH 13.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Danimer IPCo. LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Daxor’s 36.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (19%) Velocity 13.3 pts (37%) Breadth 7.9 pts (22%) Claim depth 8.3 pts (23%)

Qualcomm Incorporated · highest

85
Daxor · this assignee

36
3D Lighting… · lowest

7

What this shows Daxor's Innovation Score is 36.3/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Daxor?

Each dot is one of Daxor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Daxor’s own 13.8 claims/patent is at or below the 16.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Daxor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Daxor's grants concentrate

Daxor Corp. is a focused PatentsView assignee: 5 CPC subclasses with 83.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2021. By volume, Daxor sits between Danimer IPCo. LLC and DBI Holding, LLC.

Daxor's three-year grant acceleration

Daxor Corp. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Danimer Ipco

6
Darco Internation…

6
Datavault AI

6
Davey Bickford

6
DAY Three Labs Ma…

6
Daye Special Steel

6
Dbappsecurity

6
DBI Holding

6
Daxor ◀

6

What this shows Daxor holds 6 patents at rank #39,746, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Daxor

By rank, the assignees closest to #39,746 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Daxor's primary technology class.

Daxor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Daxor Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	33.3%
2021	1	16.7%
2023	1	16.7%
2024	1	16.7%
2025partial year	1	16.7%

Which technologies does Daxor Corp. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Daxor Corp.'s patent record in context - here's where to go next.

Daxor Corp.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 83.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #39,758 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Daxor Corp. against Danimer IPCo. LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.